if CPACS is the ‘holy grail’ as per Aaron then why would a clinical cardio-oncologist turn down CAB role. Either it’s too soon have to wait until IND and US trial or contracts / conflicts of interest preventing engagement.
Perhaps we see more direction on this as part of Board changes version 2.0.
If I had to take a guess Susan won’t be CAB until validation in the clinic. It’s a huge reputational risk until then IMO. But also once in a lifetime and the pinnacle of what cardio-oncologists pursue their entire career.
Add to My Watchlist
What is My Watchlist?
